MAINTENANCE THERAPY IN MYELOMA - RISK VERSUS BENEFIT

被引：0
|
作者：
JACOBS, P [1 ]
DUBOVSKY, D [1 ]
KING, HS [1 ]
机构：
[1] UNIV CAPE TOWN,CAPE TOWN,SOUTH AFRICA
来源：
BRITISH MEDICAL JOURNAL | 1975年 / 3卷 / 5981期
关键词：
D O I：
10.1136/bmj.3.5981.490
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：490 / 490
页数：1
相关论文
共 50 条
  • [31] Pain as a risk factor of depression and anxiety symptoms with multiple myeloma during maintenance therapy
    Shi, Hui
    Ren, Honglin
    Tian, Ying
    Chen, Zhe
    Xu, Cuiping
    Lu, Lu
    Ma, Xiaoyu
    Li, Xiaoyan
    Chen, Wenming
    Guo, Tong
    Fan, Cuizhen
    Gao, Wen
    FRONTIERS IN PSYCHOLOGY, 2022, 13
  • [32] Maintenance therapy with bortezomib and dexamethasone after autotransplantation for high-risk multiple myeloma
    Mancuso, Katia
    Tacchetti, Paola
    Pantani, Lucia
    Rocchi, Serena
    Rizzello, Ilaria
    Caratozzolo, Isola
    De Cicco, Gabriella
    Fusco, Alessio
    Testoni, Nicoletta
    Terragna, Carolina
    Marzocchi, Giulia
    Martello, Marina
    Borsi, Enrica
    Dozza, Luca
    Cavo, Michele
    Zamagni, Elena
    BONE MARROW TRANSPLANTATION, 2020, 55 (09) : 1865 - 1867
  • [33] Maintenance therapy with bortezomib and dexamethasone after autotransplantation for high-risk multiple myeloma
    Katia Mancuso
    Paola Tacchetti
    Lucia Pantani
    Serena Rocchi
    Ilaria Rizzello
    Isola Caratozzolo
    Gabriella De Cicco
    Alessio Fusco
    Nicoletta Testoni
    Carolina Terragna
    Giulia Marzocchi
    Marina Martello
    Enrica Borsi
    Luca Dozza
    Michele Cavo
    Elena Zamagni
    Bone Marrow Transplantation, 2020, 55 : 1865 - 1867
  • [34] HEPATOTOXICITY, OTHER ADVERSE EFFECTS, AND CF DRUG THERAPY: RISK VERSUS BENEFIT
    Phan, Hanna
    PEDIATRIC PULMONOLOGY, 2010, : 206 - 208
  • [35] Recommend maintenance therapy with lenalidomide in multiple myeloma
    Manasanch, Elisabet E.
    SEMINARS IN ONCOLOGY, 2016, 43 (06) : 712 - 713
  • [36] What is the Best Maintenance Therapy for Multiple Myeloma
    Mele, G.
    Pinna, S.
    Loseto, G.
    Melpignano, A.
    Quarta, G.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S77 - S77
  • [37] Critical appraisal of consolidation versus maintenance versus 2nd high dose therapy in multiple myeloma (MM) first line therapy
    Willenbacher, W.
    Willenbacher, E.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 222 - 223
  • [38] Risk Versus Benefit of Combined Aspirin and Warfarin Therapy in Patients With Atrial Fibrillation
    Nagaraj, Tara A.
    Snider, Melissa J.
    Davidson, Erica
    Weiss, Raul
    Li, Junan
    Afzal, Muhammad
    JOURNAL OF PHARMACY PRACTICE, 2021, 34 (05) : 766 - 773
  • [39] Iodine-131-metaiodobenzylguanidine dosimetry in cancer therapy: Risk versus benefit
    Tristam, M
    Alaamer, AS
    Fleming, JS
    Lewington, VJ
    Zivanovic, MA
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (06) : 1058 - 1063
  • [40] Oral ixazomib maintenance therapy in multiple myeloma
    Offidani, Massimo
    Corvatta, Laura
    Gentili, Silvia
    Maracci, Laura
    Leoni, Pietro
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (01) : 21 - 32
12345